Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “AVALO THERAPEUTICS, INC.”

4 pharma patents match "AVALO THERAPEUTICS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "AVALO THERAPEUTICS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “AVALO THERAPEUTICS, INC.” · 30,257 patents in full index Clear search

  1. US 12410153

    Compounds, compositions and methods

    AVALO THERAPEUTICS, INC. · Granted Sep 9, 2025 · Expires Sep 4, 2045

    granted
  2. US 12331107

    Methods of treating pneumonia or respiratory failure associated with COVID-19 by administering an anti-LIGHT antibody

    AVALO THERAPEUTICS, INC. · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  3. US 11708406

    Method of treating acute respiratory distress syndrome (ARDS) or acute lung injury (ALI) associate with COVID-19 by administering an anti-LIGHT antibody

    AVALO THERAPEUTICS, INC. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  4. US 11479576

    Nucleic acid prodrugs

    AVALO THERAPEUTICS, INC. · Granted Oct 25, 2022 · Expires Oct 20, 2042

    granted